What does "AI visibility" mean for my business?

When someone asks ChatGPT, Claude, or Gemini "what is the best..." or "where can I find...", AI gives specific recommendations. AI visibility is a measure of how often — and how positively — these AI platforms mention your business. It's the new version of being on the first page of Google, except now there are no pages — just one answer.

Which AI platforms do you monitor?

Pendium monitors ChatGPT, Claude, Gemini, Grok, Perplexity, DeepSeek, and Google AI Overviews — seven major AI platforms that consumers use to research local services. We run real queries that your customers actually ask and analyze the responses for mentions of your business, competitors, and industry topics.

How does Pendium improve my visibility?

Three ways. First, we identify the exact queries and topics where you're invisible. Second, we generate AI-optimized content — articles, guides, social posts — designed to help AI agents understand your business and recommend your services to the right people. Third, we continuously monitor to track improvement and find new opportunities. Most clients see measurable improvement within 60 days.

How long until I see results?

You'll get your first visibility report within minutes of signing up. Actual visibility improvement varies, but our clients typically see a 47% average improvement within 60 days. Some see results faster — it depends on your current online presence and how competitive your local market is.

Do I need to be technical to use this?

Not at all. Enter your website URL and Pendium handles everything: scanning AI platforms, analyzing your visibility, generating content, and tracking improvement. The dashboard is designed for business owners, not engineers. If you can check your email, you can use Pendium.

What makes this different from SEO?

Traditional SEO optimizes for Google's search rankings — blue links on a results page. AI visibility is different: AI doesn't show links, it gives direct answers. Even if you rank #1 on Google, ChatGPT might recommend a competitor. Pendium optimizes for the new paradigm — making sure AI platforms know about, trust, and recommend your business.

Businesses/Pharmaceuticals & Biotechnology/Pfizer Inc.

AI Visibility & Sentiment

Pfizer Inc.

Pfizer Inc. is a leading global biopharmaceutical company dedicated to the discovery, development, and distribution of medicines and vaccines. Recently undergoing a strategic shift to focus on high-science oncology, the company leverages its massive R&D budget to treat complex diseases and improve global health outcomes.

Active Monitoring

pfizer.com

Pharmaceuticals & Biotechnology

Partial scan

AI Visibility Score

94/100

Excellent

Sentiment Score

64/100

Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core

adjacent

aspirational

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Pfizer Inc. today.

Pfizer maintains a strong foothold in AI search environments when directly queried, yet experiences significant visibility gaps in high-science oncology and broader therapeutic landscapes. While the brand successfully anchors its presence for chronic care patients, it currently cedes market share to competitors like Kisqali and Verzenio in critical treatment-alternatives queries.

Working in your favor

Secures the top position in AI Overviews for direct brand queries and chronic disease management for blood thinners.

High resonance with chronic care patient advocates, maintaining an 80% mention rate.

Strong performance within core and adjacent categories, indicating that search algorithms recognize Pfizer as a primary industry authority.

Gaps to close

Systemic absence in high-science oncology discussions, particularly regarding antibody-drug conjugates and metastatic breast cancer treatment alternatives.

Underperformance in trust-based queries where the brand should logically appear as a leader but is currently omitted.

Lack of visibility in aspirational reach queries, missing opportunities to position the brand in broader healthcare innovation conversations.

Opportunities

Optimizing technical documentation and thought leadership content around antibody-drug conjugates to capture oncology market share.

Strengthening trust-signaling content to ensure prominence in queries regarding pharmaceutical reliability and corporate reputation.

Leveraging high-intent patient advocate trust to transition into broader clinical researcher audience conversations.

Highest-Impact Actions

Develop and syndicate specialized clinical content focused on antibody-drug conjugates and CDK4/6 inhibitors.

Competitors are currently dominating these high-value oncology queries, and establishing Pfizer as a core reference here is essential for capturing professional intent.

Implement a trust-transparency schema on corporate and therapeutic landing pages.

The brand is missing from trust-based queries; clear, machine-readable indicators of clinical excellence and safety standards will improve AI retrieval confidence.

Expand content strategy to target clinical researcher personas with data-driven clinical trial summaries.

Current visibility among researchers is lower than with patients; deeper clinical depth will help close the gap in scientific search environments.

Value Proposition

Pfizer combines unmatched commercial scale with an R&D 'Barbell Strategy,' allowing them to manage a portfolio of primary care blockbusters while simultaneously scaling advanced 'high-science' breakthroughs like Antibody-Drug Conjugates.

Overview

Mission

Breakthroughs that change patients' lives.

Products & Services

Eliquis (apixaban)Prevnar 20Vyndaqel/Vyndamax (tafamidis)Ibrance (palbociclib)Padcev (enfortumab vedotin-ejfv)

Current State

Visibility Landscape

A high-level view of how Pfizer Inc. performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

	ChatGPT	Claude	Gemini	AI Overviews
Reputation1q Brand recognition & direct queries	—	—	—	97
Core4q Product/service category queries	—	—	—	94
Growth Areas4q Adjacent, aspirational & visionary	—	—	—	0

Competitive Landscape

Xarelto3 mentions

Pradaxa3 mentions

Savaysa3 mentions

Coumadin3 mentions

Pfizer Inc.3 mentions

Kisqali2 mentions

Verzenio2 mentions

Attruby2 mentions

Amvuttra2 mentions

Itovebi1 mention

Dalpiciclib1 mention

Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Pfizer Inc.'s AI visibility.

Key Findings

Strength

Secures the top position in AI Overviews for direct brand queries and chronic disease management for blood thinners.

Strength

High resonance with chronic care patient advocates, maintaining an 80% mention rate.

Strength

Strong performance within core and adjacent categories, indicating that search algorithms recognize Pfizer as a primary industry authority.

Recommended Actions

Develop and syndicate specialized clinical content focused on antibody-drug conjugates and CDK4/6 inhibitors.

Competitors are currently dominating these high-value oncology queries, and establishing Pfizer as a core reference here is essential for capturing professional intent.

Implement a trust-transparency schema on corporate and therapeutic landing pages.

The brand is missing from trust-based queries; clear, machine-readable indicators of clinical excellence and safety standards will improve AI retrieval confidence.

Expand content strategy to target clinical researcher personas with data-driven clinical trial summaries.

Current visibility among researchers is lower than with patients; deeper clinical depth will help close the gap in scientific search environments.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

Chronic Disease Management & Medication Selection(3 queries)

“what are the most reliable blood thinners for long-term management after a DVT diagnosis”

1/1 platforms mentioned

Core

AI Overviews

1.Eliquis

2.Xarelto

3.Pradaxa

4.Savaysa

5.Coumadin

“can you recommend some common treatments for ATTR cardiomyopathy that have good clinical data”

1/1 platforms mentioned

Core

Global Health Procurement Lead · Procurement Officer

AI Overviews

1.Attruby

2.Amvuttra

“what are the standard vaccines recommended for someone over 60 with a compromised immune system”

0/0 platforms mentioned

Adjacent

Global Health Procurement Lead · Procurement Officer

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

Anticoagulation in Deep Venous Thrombosis - Medscape Reference

emedicine.medscape.com

Web1 ref

Choosing the most beneficial blood thinner

health.harvard.edu

Edu1 ref

Deep Venous Thrombosis - StatPearls - NCBI Bookshelf

ncbi.nlm.nih.gov

Gov1 ref

Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Factor Xa Inhibitors for DVT: What to Know - WebMD

webmd.com

Web1 ref

Deep vein thrombosis (DVT) - Diagnosis & treatment

mayoclinic.org

Web1 ref

Xarelto vs. Eliquis: Similarities and differences

medicalnewstoday.com

Web1 ref

Xarelto vs. Eliquis: Which is better for blood clots? - SingleCare

singlecare.com

Web1 ref

Deep Venous Thrombosis and Pulmonary Embolism - AAFP

aafp.org

Web1 ref

Warfarin versus direct oral anticoagulants for patients needing ...

jvsvenous.org

Web1 ref

Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Current State of Anticoagulants to Treat Deep Venous Thrombosis

pmc.ncbi.nlm.nih.gov

Gov1 ref

Xarelto vs. Eliquis: What's the Difference? - Healthline

healthline.com

Web1 ref

2026 Guideline for the Evaluation and Management of Acute ...

professional.heart.org

Web1 ref

How Long Should You Use Blood Thinners for DVT?

baptisthealthsystem.com

Web1 ref

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned March 16, 2026.

Pfizer Inc.

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Sample Conversations

Citations

Engineer content that makes AI agents recommend you

Start getting
recommended by AI.

Frequently asked questions

Pfizer Inc.

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Sample Conversations

Citations

Engineer content that makes AI agents recommend you

Start gettingrecommended by AI.

Frequently asked questions

Start getting
recommended by AI.